vs

Side-by-side financial comparison of agilon health, inc. (AGL) and Taylor Morrison Home Corp (TMHC). Click either name above to swap in a different company.

agilon health, inc. is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.1× Taylor Morrison Home Corp). Taylor Morrison Home Corp runs the higher net margin — 7.1% vs -12.0%, a 19.1% gap on every dollar of revenue. On growth, agilon health, inc. posted the faster year-over-year revenue change (3.1% vs -26.8%). Over the past eight quarters, agilon health, inc.'s revenue compounded faster (-1.1% CAGR vs -16.5%).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

Taylor Morrison is one of the largest home building companies in the United States. Its corporate headquarters are in Scottsdale, Arizona. The company formed when Taylor Woodrow and Morrison Homes joined forces in July 2007. Taylor Morrison operates in Arizona, California, Colorado, Georgia, Florida, North Carolina, South Carolina, Nevada, Indiana, and Texas, building mid-to-upscale housing, as well as first-time and mid-market homes.

AGL vs TMHC — Head-to-Head

Bigger by revenue
AGL
AGL
1.1× larger
AGL
$1.6B
$1.4B
TMHC
Growing faster (revenue YoY)
AGL
AGL
+29.9% gap
AGL
3.1%
-26.8%
TMHC
Higher net margin
TMHC
TMHC
19.1% more per $
TMHC
7.1%
-12.0%
AGL
Faster 2-yr revenue CAGR
AGL
AGL
Annualised
AGL
-1.1%
-16.5%
TMHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AGL
AGL
TMHC
TMHC
Revenue
$1.6B
$1.4B
Net Profit
$-188.9M
$98.6M
Gross Margin
21.0%
Operating Margin
-12.3%
Net Margin
-12.0%
7.1%
Revenue YoY
3.1%
-26.8%
Net Profit YoY
-78.5%
-53.8%
EPS (diluted)
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
TMHC
TMHC
Q1 26
$1.4B
Q4 25
$1.6B
$2.1B
Q3 25
$1.4B
$2.1B
Q2 25
$1.4B
$2.0B
Q1 25
$1.5B
$1.9B
Q4 24
$1.5B
$2.4B
Q3 24
$1.5B
$2.1B
Q2 24
$1.5B
$2.0B
Net Profit
AGL
AGL
TMHC
TMHC
Q1 26
$98.6M
Q4 25
$-188.9M
$174.0M
Q3 25
$-110.2M
$201.4M
Q2 25
$-104.4M
$193.6M
Q1 25
$12.1M
$213.5M
Q4 24
$-105.8M
$242.5M
Q3 24
$-117.6M
$251.1M
Q2 24
$-30.7M
$199.5M
Gross Margin
AGL
AGL
TMHC
TMHC
Q1 26
21.0%
Q4 25
22.0%
Q3 25
22.7%
Q2 25
23.0%
Q1 25
24.4%
Q4 24
23.9%
Q3 24
25.0%
Q2 24
23.7%
Operating Margin
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
-12.3%
Q3 25
-9.1%
Q2 25
-8.3%
Q1 25
-1.4%
Q4 24
-7.1%
Q3 24
-9.2%
Q2 24
-2.9%
Net Margin
AGL
AGL
TMHC
TMHC
Q1 26
7.1%
Q4 25
-12.0%
8.3%
Q3 25
-7.7%
9.6%
Q2 25
-7.5%
9.5%
Q1 25
0.8%
11.3%
Q4 24
-6.9%
10.3%
Q3 24
-8.1%
11.8%
Q2 24
-2.1%
10.0%
EPS (diluted)
AGL
AGL
TMHC
TMHC
Q1 26
$1.12
Q4 25
$1.77
Q3 25
$2.01
Q2 25
$1.92
Q1 25
$2.07
Q4 24
$2.29
Q3 24
$2.37
Q2 24
$1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
TMHC
TMHC
Cash + ST InvestmentsLiquidity on hand
$173.7M
$652.9M
Total DebtLower is stronger
$35.0M
Stockholders' EquityBook value
$126.7M
$6.2B
Total Assets
$1.3B
$9.8B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
TMHC
TMHC
Q1 26
$652.9M
Q4 25
$173.7M
$850.0M
Q3 25
$171.7M
$370.6M
Q2 25
$171.4M
$130.2M
Q1 25
$136.9M
$377.8M
Q4 24
$188.2M
$487.2M
Q3 24
$148.2M
$256.4M
Q2 24
$109.5M
$246.8M
Total Debt
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
$35.0M
$2.3B
Q3 25
$2.2B
Q2 25
$2.1B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.2B
Stockholders' Equity
AGL
AGL
TMHC
TMHC
Q1 26
$6.2B
Q4 25
$126.7M
$6.3B
Q3 25
$306.1M
$6.2B
Q2 25
$408.9M
$6.1B
Q1 25
$500.3M
$6.0B
Q4 24
$471.0M
$5.9B
Q3 24
$574.9M
$5.7B
Q2 24
$676.6M
$5.5B
Total Assets
AGL
AGL
TMHC
TMHC
Q1 26
$9.8B
Q4 25
$1.3B
$9.8B
Q3 25
$1.6B
$9.6B
Q2 25
$1.7B
$9.5B
Q1 25
$1.9B
$9.4B
Q4 24
$1.7B
$9.3B
Q3 24
$2.1B
$9.3B
Q2 24
$2.2B
$9.1B
Debt / Equity
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
0.28×
0.36×
Q3 25
0.35×
Q2 25
0.35×
Q1 25
0.35×
Q4 24
0.36×
Q3 24
0.37×
Q2 24
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
TMHC
TMHC
Operating Cash FlowLast quarter
$-20.5M
Free Cash FlowOCF − Capex
$-23.5M
FCF MarginFCF / Revenue
-1.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-119.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
$-20.5M
$646.4M
Q3 25
$-18.2M
$219.6M
Q2 25
$-35.1M
$-126.0M
Q1 25
$-32.0M
$77.2M
Q4 24
$16.4M
$438.2M
Q3 24
$-7.7M
$135.9M
Q2 24
$-18.7M
$-233.3M
Free Cash Flow
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
$-23.5M
$635.3M
Q3 25
$-21.3M
$206.6M
Q2 25
$-38.3M
$-133.6M
Q1 25
$-35.8M
$68.7M
Q4 24
$13.2M
$428.2M
Q3 24
$-11.2M
$127.1M
Q2 24
$-22.0M
$-241.7M
FCF Margin
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
-1.5%
30.3%
Q3 25
-1.5%
9.9%
Q2 25
-2.7%
-6.6%
Q1 25
-2.3%
3.6%
Q4 24
0.9%
18.2%
Q3 24
-0.8%
6.0%
Q2 24
-1.5%
-12.1%
Capex Intensity
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
0.2%
0.5%
Q3 25
0.2%
0.6%
Q2 25
0.2%
0.4%
Q1 25
0.3%
0.4%
Q4 24
0.2%
0.4%
Q3 24
0.2%
0.4%
Q2 24
0.2%
0.4%
Cash Conversion
AGL
AGL
TMHC
TMHC
Q1 26
Q4 25
3.71×
Q3 25
1.09×
Q2 25
-0.65×
Q1 25
-2.64×
0.36×
Q4 24
1.81×
Q3 24
0.54×
Q2 24
-1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

TMHC
TMHC

Home closings revenue, net$1.3B95%
Financial services revenue, net$49.3M4%
Land closings revenue$14.5M1%
Amenity and other revenue$11.9M1%

Related Comparisons